Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer-Reference-Cited by-同舟云学术

Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer

Published:2022-02 Issue:1 Volume:192 Page:153-161
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Ganz Patricia A.^ORCID,Bandos Hanna,Geyer Charles E.,Robidoux André,Paterson Alexander H. G.,Polikoff Jonathan,Baez-Diaz Luis,Brufsky Adam M.,Fehrenbacher Louis,Parsons Ann W.,Ward Patrick J.,Provencher Louise,Hamm John T.,Stella Philip J.,Carolla Robert L.,Margolese Richard G.,Shibata Henry R.,Perez Edith A.,Wolmark Norman

Funder

national cancer institute

pharmacia & upjon

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-021-06475-2.pdf

Reference15 articles.

1. Paik S, Shak S, Tang, et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817–2826. https://www.ncbi.nlm.nih.gov/pubmed/?term=15591335

2. Paik S, Tang G, Shak S, et al (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24:3726–3734. https://www.ncbi.nlm.nih.gov/pubmed/?term=16720680

3. Early stage breast cancer. Consens Statement 8(6):1–19. Review. https://www.ncbi.nlm.nih.gov/pubmed/2247093. Accessed 18–21 Jun 1990

4. Brady MJ, Cella DF, Mo F, et al (1997) Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 15:974–986. https://www.ncbi.nlm.nih.gov/pubmed/?term=9060536

5. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483. https://www.ncbi.nlm.nih.gov/pubmed/?term=1593914

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology);Breast Cancer Research and Treatment;2022-03-01